Zobrazeno 1 - 10
of 51
pro vyhledávání: '"De Claro RA"'
Autor:
Hunter AM; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Itzykson R; Université Paris Cité, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, Centre National de la Recherche Scientifique, Paris, France.; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mesa R; Hematology and Medical Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC., Karanes C; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Li Y; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., de Claro RA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Norsworthy KJ; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Theoret M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Pulte E; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Padron E; Hematologic Malignancies. H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Publikováno v:
Blood [Blood] 2024 Nov 07; Vol. 144 (19), pp. 1987-1992.
Autor:
Woods AC; United States Food and Drug Administration, Silver Spring, Maryland, United States., Norsworthy KJ; United States Food and Drug Administration, Silver Spring, MD, United States., Choe M; United States Food and Drug Administration, Silver Spring, Maryland, United States., Gehrke BJ; Food and Drug Administration, White Oak, MD, United States., Chen H; United States Food and Drug Administration, Silver Spring, Maryland, United States., Vallejo J; United States Food and Drug Administration, Silver Spring, MD, United States., Pan L; United States Food and Drug Administration, Silver Spring, Maryland, United States., Jiang X; United States Food and Drug Administration, Silver Spring, Maryland, United States., Li H; United States Food and Drug Administration, Silver Spring, Maryland, United States., Kraft J; United States Food and Drug Administration, United States., Liu J; United States Food and Drug Administration, United States., Charlab R; United States Food and Drug Administration, Silver Spring, MD, United States., Okusanya OO; United States Food and Drug Administration, Silver Spring, MD, United States., Booth B; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Md, United States., Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States., Theoret MR; Food and Drug Administration, Silver Spring, MD, United States., de Claro RA; United States Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.
Autor:
Hermans SJF; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Maas NG; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., van Norden Y; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Berkx E; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Huijgens PC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Rivera DR; US Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Pignatti F; Oncology and Hematology Office, European Medicines Agency, Amsterdam, the Netherlands., Versluis J; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Oncology and Hematology Office, European Medicines Agency, Amsterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1426-1436.
Autor:
Pamuk GE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chow ECY; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ionan AC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chen H; Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee SL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hsu V; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Grimstein M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zheng N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Sun J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gehrke BJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Vallejo J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ehrlich LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4266-4271.
Autor:
Al-Juhaishi T; Oklahoma Health Sciences Center, University of Oklahoma, Oklahoma City, OK, USA., Dela Cruz S; Florida Cancer Specialists & Research Institute, Inverness, FL, USA., Gupta R; The Center for Cancer and Blood Disorders, Fort Worth, TX, USA., Keiffer G; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Morrison VA; Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA., Shapira I; Regional Cancer Care Associates, Teaneck, NJ, USA., Woods A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Norsworthy K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Garg R; Maryland Oncology and Hematology, Annapolis, MD, USA., Pulte ED; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 801-805.
Autor:
Cortes JE; Georgia Cancer Center at Augusta University, Augusta, Georgia., Abruzzese E; Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy., Cardonick EH; Cooper Medical School of Rowan University, Camden, New Jersey., Hernández-Díaz S; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Gutierrez J; Patient advocate, Castle Pines, Colorado., Sardegna MS; Patient advocate, Laguna Hills, California., Torres-Chavez E; Patient advocate, Riverside, California., Dinatale M; FDA, Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Silver Spring, Maryland., Lerro CC; FDA, Oncology Center of Excellence, Silver Spring, Maryland., Gehrke BJ; FDA, Center for Drug Evaluation and Research, Office of Oncologic Diseases, Silver Spring, Maryland., Shord SS; FDA, Center for Drug Evaluation and Research, Office of Clinical Pharmacology, Silver Spring, Maryland., De Claro RA; FDA, Center for Drug Evaluation and Research, Office of Oncologic Diseases, Silver Spring, Maryland., Theoret MR; FDA, Oncology Center of Excellence, Silver Spring, Maryland., DeMaria PJ; FDA, Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Silver Spring, Maryland., Norsworthy KJ; FDA, Center for Drug Evaluation and Research, Office of Oncologic Diseases, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3658-3666.
Autor:
Le RQ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Przepiorka D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Chen H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Shen YL; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Pulte ED; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Norsworthy K; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Theoret MR; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., De Claro RA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
Blood [Blood] 2024 Jul 11; Vol. 144 (2), pp. 206-215.
Autor:
Woods A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Norsworthy KJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Wang X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Vallejo J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chiu Yuen Chow E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li RJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Sun J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jiang X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1226-1231.
Autor:
Sweet KL; Moffitt Cancer Center, Tampa, Florida., Cortes JE; Georgia Cancer Center, Augusta University, Augusta, Georgia., Apperley JF; Centre for Haematology, Imperial College, London, United Kingdom., Mann M; Patient Advocate, Jonesboro, Georgia., Mauro MJ; Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York City, New York., Oehler VG; Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington., Ruiz C; Patient Advocate, Jonesboro, Georgia., Schiffer CA; Department of Hematology-Oncology, Karmanos Cancer Center at Wayne State University, Detroit, Michigan., Ehrlich LA; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Pamuk GE; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Wynne J; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Mehta GU; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Okusanya OO; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., de Claro RA; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Theoret MR; Oncology Center of Excellence, FDA, Washington, District of Columbia., Smith BD; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Norsworthy KJ; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 237-238.
Autor:
Donaldson JM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Seddiq M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fusco MJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Singla S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pamuk GE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee-Alonso RJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Mixter BD; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Drezner N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kanapuru B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fashoyin-Aje LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Dec 12; Vol. 13 (12), pp. 2515-2524.